In part 2, Dr Mikhail Kosiborod and Dr Arun Sanyal dissect the results of a recent publication reporting the efficacy and safety of the GLP-1 RA semaglutide in a population of NASH patients.

Recorded remotely from Kansas City and Virginia, 2020.